Structural analysis of purified human tracheobronchial mucins

Area of Science:

• Biochemistry
• Biophysics
• Molecular Biology

Background:

• Cystic fibrosis (CF) is a genetic disorder affecting mucus production.
• Human tracheobronchial mucin glycoproteins (HTBM) are key components of airway mucus.
• Understanding HTBM structure is crucial for CF research.

Purpose of the Study:

• To investigate the molecular structure and conformation of HTBM from CF patients.
• To determine the molecular weight and size of HTBM fractions.
• To compare the structure of CF HTBM with other known mucins.

Main Methods:

• Extraction of HTBM using guanidinium hydrochloride.
• Fractionation by gel exclusion chromatography and density gradient ultracentrifugation.
• Characterization using light scattering, SDS-PAGE, and UV spectroscopy.

Main Results:

• Native CF HTBM showed high molecular weight fractions (Mw = 9.3 x 10^6 Da) and degraded fractions.
• Reduced and carboxymethylated HTBM yielded fractions with Mw of 5.1 x 10^6, 1.6 x 10^6, and 400,000 Da.
• Derived protein core molecular weights and radii of gyration matched established mucin relationships.

Conclusions:

• CF HTBM shares an extended-coil conformation with other mucins.
• HTBM possesses a subunit structure linked by disulfide bonds.
• These findings contribute to understanding mucin structure in cystic fibrosis.